Home › Funds › Jones Hill Capital LP › ARQT
Jones Hill Capital LP position in ARQT
ARCUTIS BIOTHERAPEUTICS INC · Health Care
Jones Hill Capital LP reported holding 1,089,701 shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$28.6M, representing 6.07% of its reported portfolio and ranking #3 among its reported holdings. Jones Hill Capital LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Jones Hill Capital LP's ARQT position evolved
Jones Hill Capital LP first disclosed a stake in ARQT in Q2 2026 at 1,089,701 shares (US$28.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.09M | $28.57M | New |
About ARQT and 13F data
ARQT (ARCUTIS BIOTHERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in ARQT — the largest reported positions include MONTANOVA CAPITAL, LLC (US$326.1M), Frazier Life Sciences Management, L.P. (US$258.9M), Rubric Capital Management LP (US$216.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARQT
- MONTANOVA CAPITAL, LLC 12.44M sh · $326.10M · Q2 2026
- Frazier Life Sciences Management, L.P. 9.87M sh · $258.91M · Q2 2026
- Rubric Capital Management LP 8.27M sh · $216.88M · Q2 2026
- ORBIMED ADVISORS LLC 2.04M sh · $53.54M · Q2 2026
- OBERWEIS ASSET MANAGEMENT INC/ 1.37M sh · $36.00M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.27M sh · $33.18M · Q2 2026
- FISHMAN JAY A LTD/MI 595.00K sh · $15.60M · Q2 2026
More on Jones Hill Capital LP
FAQ
How long has Jones Hill Capital LP held ARQT?
Jones Hill Capital LP has disclosed ARQT holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Jones Hill Capital LP's current position in ARQT?
As of Q2 2026, Jones Hill Capital LP holds 1.09M shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), valued at $28.57M, representing 6.07% of its reported portfolio and ranking #3.
Has Jones Hill Capital LP been buying or selling ARQT?
In the latest 13F filing (Q2 2026), Jones Hill Capital LP newly opened its position in ARQT.
Which other funds hold ARQT?
Other major institutional holders of ARQT include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., Rubric Capital Management LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.